" “Hard to accept that these imbeciles represent the people in our government.”
Martin Shkreli is 100 % right
they and their stupid rules and the sheep /lemming like American population is the main reason why we are the developed nation spending maximum dollars with minimal health returns.
Also maybe he was thinking, If I have to pay a million $ for an unknown hip-hop album patients should pay at least &50$ for a medicine which was originally $13,50.
Drug Goes From $13.50 a Tablet to $750, Overnight
There's nothing wrong with some well-placed rage. But the hatred of Shkreli seems to have accomplished little. The loopholes he exploited when he jacked up the price of Daraprim, a lifesaving drug for immunocompromised patients, 5,000% are still wide open.In the end, in spite of himself, Shkreli proved that as a culture we don't care about the details, we're transfixed by spectacle, and that we don't want to fix our problems. You really hate Martin? How about actually trying to accomplish real change
"Nancy Retzlaff, Turing’s chief commercial officer, told the committee about her company’s efforts to get the drug to people who can’t afford it. The arrangement she described sounded like a hodge-podge, an ungainly combination of dizzyingly high prices, mysterious corporate bargaining, and occasional charitable acts—which is to say, it sounded not so much different from the rest of our medical system.
A truly greedy executive would keep a much lower profile than Shkreli: there would be no headline-grabbing exponential price hikes, just boring but reliable ticks upward; no interviews, no tweeting, and absolutely no hip-hop feuds. A truly greedy executive would stay more or less anonymous. (How many other pharmaceutical C.E.O.s can you name?) But Shkreli seems intent on proving a point about money and medicine, and you don't have to agree with his assessment in order to appreciate the service he has done us all. Bv showingBy showing what is legal, he has helped us to think about what we might want to change, and what we might need to learn to live with
"Nancy Retzlaff, Turing’s chief commercial officer, told the committee about her company’s efforts to get the drug to people who can’t afford it. The arrangement she described sounded like a hodge-podge, an ungainly combination of dizzyingly high prices, mysterious corporate bargaining, and occasional charitable acts—which is to say, it sounded not so much different from the rest of our medical system.
A truly greedy executive would keep a much lower profile than Shkreli: there would be no headline-grabbing exponential price hikes, just boring but reliable ticks upward; no interviews, no tweeting, and absolutely no hip-hop feuds. A truly greedy executive would stay more or less anonymous. (How many other pharmaceutical C.E.O.s can you name?) But Shkreli seems intent on proving a point about money and medicine, and you don't have to agree with his assessment in order to appreciate the service he has done us all. Bv showingBy showing what is legal, he has helped us to think about what we might want to change, and what we might need to learn to live with
No comments:
Post a Comment